Noven’s Media Center gives you immediate access to current and archived press releases.
Please note that news releases appearing on this website are presented for historical reference, have not been updated for current events, and are current only as of their respective dates of issuance.
- Noven Files Patent Infringement Lawsuit Against Actavis - (10/16/14)
- Noven Announces Publication of Exploratory Analyses from Pooled Phase 3 Results of the Effects of Brisdelle® (Paroxetine) Capsules on Weight and Sexual Function During Treatment of Vasomotor Symptoms Associated with Menopause - (10/14/14)
- Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) - (09/24/14)
- Noven Appoints Krista Roberts as Vice President of Operations - (06/23/14)
- Noven Announces Settlement of Lidoderm® Patent Litigation - (04/16/14)
- Noven Pharmaceuticals Announces Issuance of New U.S. Patent, an Important Addition to its Intellectual Property Portfolio for Brisdelle® (Paroxetine) Capsules, 7.5 mg - (03/25/14)
- Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle™ (Paroxetine) Capsules - (01/13/14)